BEDFORD, Mass.--(BUSINESS WIRE)--CIS-US, Inc. announced today that it has received approval from the U. S. Food and Drug Administration (FDA) Office of Generic Drugs for its Abbreviated New Drug Application (ANDA) to manufacture and market a generic Kit for the Preparation of Technetium Tc-99m Mebrofenin. The company will begin distribution the week of February 4.
